Imiquimod-induced subacute cutaneous lupus erythematosus-like changes

Sheilagh Maguiness, Terry T. Farsani, Daniel C. Zedek, Timothy G. Berger

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Imiquimod is a topical immunomodulator used to treat genital warts and cutaneous malignancies that exerts its effects via induction of proinflammatory cytokines through activation of toll-like receptor (TLR) 7. Although subacute cutaneous lupus erythematosus (SCLE) has been reported in association with multiple systemic medications, SCLE in patients treated with topical agents has not been widely reported. We report the case of a 50-year-old woman with local induction of lesions that clinically and histologically resembled SCLE following treatment with topical imiquimod.

Original languageEnglish (US)
Pages (from-to)349-351
Number of pages3
JournalCutis
Volume95
Issue number6
StatePublished - Jan 1 2015

Fingerprint

imiquimod
Cutaneous Lupus Erythematosus
Toll-Like Receptor 7
Condylomata Acuminata
Immunologic Factors
Cytokines
Skin
Neoplasms

Cite this

Maguiness, S., Farsani, T. T., Zedek, D. C., & Berger, T. G. (2015). Imiquimod-induced subacute cutaneous lupus erythematosus-like changes. Cutis, 95(6), 349-351.

Imiquimod-induced subacute cutaneous lupus erythematosus-like changes. / Maguiness, Sheilagh; Farsani, Terry T.; Zedek, Daniel C.; Berger, Timothy G.

In: Cutis, Vol. 95, No. 6, 01.01.2015, p. 349-351.

Research output: Contribution to journalArticle

Maguiness, S, Farsani, TT, Zedek, DC & Berger, TG 2015, 'Imiquimod-induced subacute cutaneous lupus erythematosus-like changes', Cutis, vol. 95, no. 6, pp. 349-351.
Maguiness S, Farsani TT, Zedek DC, Berger TG. Imiquimod-induced subacute cutaneous lupus erythematosus-like changes. Cutis. 2015 Jan 1;95(6):349-351.
Maguiness, Sheilagh ; Farsani, Terry T. ; Zedek, Daniel C. ; Berger, Timothy G. / Imiquimod-induced subacute cutaneous lupus erythematosus-like changes. In: Cutis. 2015 ; Vol. 95, No. 6. pp. 349-351.
@article{ce50d1e2e9b14dde8d07de4ac294ff17,
title = "Imiquimod-induced subacute cutaneous lupus erythematosus-like changes",
abstract = "Imiquimod is a topical immunomodulator used to treat genital warts and cutaneous malignancies that exerts its effects via induction of proinflammatory cytokines through activation of toll-like receptor (TLR) 7. Although subacute cutaneous lupus erythematosus (SCLE) has been reported in association with multiple systemic medications, SCLE in patients treated with topical agents has not been widely reported. We report the case of a 50-year-old woman with local induction of lesions that clinically and histologically resembled SCLE following treatment with topical imiquimod.",
author = "Sheilagh Maguiness and Farsani, {Terry T.} and Zedek, {Daniel C.} and Berger, {Timothy G.}",
year = "2015",
month = "1",
day = "1",
language = "English (US)",
volume = "95",
pages = "349--351",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "6",

}

TY - JOUR

T1 - Imiquimod-induced subacute cutaneous lupus erythematosus-like changes

AU - Maguiness, Sheilagh

AU - Farsani, Terry T.

AU - Zedek, Daniel C.

AU - Berger, Timothy G.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Imiquimod is a topical immunomodulator used to treat genital warts and cutaneous malignancies that exerts its effects via induction of proinflammatory cytokines through activation of toll-like receptor (TLR) 7. Although subacute cutaneous lupus erythematosus (SCLE) has been reported in association with multiple systemic medications, SCLE in patients treated with topical agents has not been widely reported. We report the case of a 50-year-old woman with local induction of lesions that clinically and histologically resembled SCLE following treatment with topical imiquimod.

AB - Imiquimod is a topical immunomodulator used to treat genital warts and cutaneous malignancies that exerts its effects via induction of proinflammatory cytokines through activation of toll-like receptor (TLR) 7. Although subacute cutaneous lupus erythematosus (SCLE) has been reported in association with multiple systemic medications, SCLE in patients treated with topical agents has not been widely reported. We report the case of a 50-year-old woman with local induction of lesions that clinically and histologically resembled SCLE following treatment with topical imiquimod.

UR - http://www.scopus.com/inward/record.url?scp=84941138624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941138624&partnerID=8YFLogxK

M3 - Article

VL - 95

SP - 349

EP - 351

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 6

ER -